Home Cart 0 Sign in  
X

[ CAS No. 2623-87-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 2623-87-2
Chemical Structure| 2623-87-2
Chemical Structure| 2623-87-2
Structure of 2623-87-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 2623-87-2 ]

Related Doc. of [ 2623-87-2 ]

Alternatived Products of [ 2623-87-2 ]

Product Details of [ 2623-87-2 ]

CAS No. :2623-87-2 MDL No. :MFCD00002817
Formula : C4H7BrO2 Boiling Point : -
Linear Structure Formula :- InChI Key :GRHQDJDRGZFIPO-UHFFFAOYSA-N
M.W : 167.00 Pubchem ID :75809
Synonyms :

Calculated chemistry of [ 2623-87-2 ]

Physicochemical Properties

Num. heavy atoms : 7
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.75
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 30.98
TPSA : 37.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.74 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.27
Log Po/w (XLOGP3) : 0.81
Log Po/w (WLOGP) : 1.25
Log Po/w (MLOGP) : 1.09
Log Po/w (SILICOS-IT) : 0.83
Consensus Log Po/w : 1.05

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.19
Solubility : 10.8 mg/ml ; 0.0649 mol/l
Class : Very soluble
Log S (Ali) : -1.18
Solubility : 11.2 mg/ml ; 0.0668 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.31
Solubility : 8.12 mg/ml ; 0.0486 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.72

Safety of [ 2623-87-2 ]

Signal Word:Danger Class:8
Precautionary Statements:P280-P305+P351+P338-P310 UN#:3261
Hazard Statements:H314 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 2623-87-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 2623-87-2 ]
  • Downstream synthetic route of [ 2623-87-2 ]

[ 2623-87-2 ] Synthesis Path-Upstream   1~12

  • 1
  • [ 67-56-1 ]
  • [ 2623-87-2 ]
  • [ 4457-67-4 ]
  • [ 33036-62-3 ]
Reference: [1] Synthesis, 2011, # 9, p. 1375 - 1382
  • 2
  • [ 67-56-1 ]
  • [ 2623-87-2 ]
  • [ 4897-84-1 ]
YieldReaction ConditionsOperation in experiment
100% at 0 - 20℃; for 18 h; Inert atmosphere Acetyl chloride (576 mg, 550 μL, 7.34 mmol) was added to a solution of 4-bromobutyric acid 4 (5.00 g, 30.0 mmol) in methanol (40 mL) cooled to 0 °C. The resulting solution was allowed to warm to room temperature and stirred for 18 h. The solution was evaporated under reduced pressure to yield methyl 4-bromobutanoate 5 (5.40 g, 30.0 mmol quant.) as acolourless oil, which was used without any further purification
85% at 0 - 20℃; Inert atmosphere Example 29: Synthesis of 4- (nitrooxy) butanoic acidO oNo2 STEP A: methyl 4-bromobutanoateTo a solution of 4-bromobutanoic acid (6.5 g, 38.9 mmol) in MeOH (120 mL) at 0°C under nitrogen atmosphere, thionyl chloride (2.8 mL, 38.9 mmol) was slowly added and the reaction was stirred overnight at room temperature Solvent was evaporated and the crude material was used directly in next step. (6.0 g, 85percent) H-NMR (CDCI3) : 3.71 (3H,s); 3.49 (2H,t J=6.44); 2.53 (2H,t J=7.16) ; 2.20 (2H,m) .
70% for 16 h; Reflux; Inert atmosphere General procedure: Typical procedure: After refluxing the mixture of 4a (7.64g, 45.7mmol), methanol (78.4mL), and conc. sulfuric acid (0.77mL) for 16h under a dry argon atmosphere, it was cooled to room temperature. Then, aqueous solution of sodium bicarbonate (78mL) was added to the reaction mixture and the crude product was extracted with ethyl acetate. After washing the combined organic layer with sodium bicarbonate aqueous solution, water, and brine, it was dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated under reduced pressure. The residue was purified by silica gel chromatography eluted with a mixed solvent of chloroform/methanol (10/1v/v). The fraction with an Rf value of 0.86 was collected and dried under reduced pressure to afford methyl 4-bromobutanoate (5a) as yellow oil (5.82g, 70percent). (0016) 1H NMR (400MHz, CDCl3, ppm): δ 2.18 (quint, J=7.0Hz, 2H, BrCH2CH2), 2.52 (quint, J=7.1Hz, 2H, Br(CH2)2CH2), 3.47 (t, J=6.4Hz, 2H, BrCH2CH2), and 3.69 (s, 3H, OCH3). 13C NMR (100MHz, CDCl3, ppm): δ 27.70 (BrCH2CH2), 32.18 (Br(CH2)2CH2), 32.68 (BrCH2), 51.71 (OCH3), and 172.98 (COOCH3). IR (NaCl, cm−1): 1738 (C=O)
Reference: [1] Tetrahedron, 2014, vol. 70, # 44, p. 8343 - 8347
[2] Chemistry - An Asian Journal, 2011, vol. 6, # 1, p. 122 - 127
[3] Patent: WO2011/92065, 2011, A1, . Location in patent: Page/Page column 75-76
[4] Journal of Pharmacology and Experimental Therapeutics, 2016, vol. 357, # 2, p. 240 - 247
[5] Journal of the American Chemical Society, 2018, vol. 140, # 17, p. 5805 - 5813
[6] Heterocycles, 2017, vol. 94, # 8, p. 1518 - 1541
[7] Reactive and Functional Polymers, 2016, vol. 99, p. 1 - 8
[8] Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1886, vol. 102, p. 369[9] Bulletin de la Societe Chimique de France, 1886, vol. <2>46, p. 65
[10] Tetrahedron, 2000, vol. 56, # 41, p. 8083 - 8094
[11] Journal of Organometallic Chemistry, 2009, vol. 694, # 3, p. 323 - 331
[12] Organic and Biomolecular Chemistry, 2009, vol. 7, # 9, p. 1821 - 1828
[13] Patent: WO2011/101245, 2011, A1, . Location in patent: Page/Page column 55
[14] Chemical Communications, 2012, vol. 48, # 46, p. 5793 - 5795
[15] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 22, p. 6981 - 6995
[16] Journal of the American Chemical Society, 2017, vol. 139, # 44, p. 15576 - 15579
  • 3
  • [ 2623-87-2 ]
  • [ 77971-32-5 ]
  • [ 4897-84-1 ]
YieldReaction ConditionsOperation in experiment
83.4% at 0 - 25℃; for 72.5 h; 4-Bromobutanoic acid (7.5 g, 45.2 mmole) was dissolved in methanol (50 mL), and then CH3SiCl(11.4 mL, 90.4 mmole) was added at 0 °C; the mixture was stirred at this temperature for 30 min andfor 72 h at 25 °C. The solvent was removed in vacuuo. The resultant residue was purified by columnchromatography (silica-gel) eluting with hexanes:ethyl acetate 90:10 to afford the title compound as acolorless oil (6.78 g, 83.4percent). 1H-NMR (CDCl3): δ 3.68 (s, 3H), 3.46 (t, J = 6.4 Hz, 2H), 2.50 (t, J = 7.2 Hz,2H), 2.22–2.13 (m, 2H). 13C-NMR (CDCl3): δ173.11, 51.85, 32.80, 32.34, 27.87. HRMS (FAB+): m/z [M]+calcd for C5H9BrO2: 179.9786, found (M + 1): 180.9786.
Reference: [1] Molecules, 2018, vol. 23, # 11,
  • 4
  • [ 186581-53-3 ]
  • [ 2623-87-2 ]
  • [ 4897-84-1 ]
Reference: [1] Canadian Journal of Chemistry, 1971, vol. 49, p. 1070 - 1084
  • 5
  • [ 64-17-5 ]
  • [ 2623-87-2 ]
  • [ 2969-81-5 ]
Reference: [1] Journal of Medicinal Chemistry, 2017, vol. 60, # 2, p. 608 - 626
[2] U.S.Atomic Energy Comm.WADC-TR-56-540 <1957>25,
[3] Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1886, vol. 102, p. 369[4] Bulletin de la Societe Chimique de France, 1886, vol. <2>46, p. 65
[5] Journal of the Chemical Society, 1937, p. 1977
[6] Journal of the American Chemical Society, 1933, vol. 55, p. 1233 - 1241
[7] ACS Chemical Neuroscience, 2017, vol. 8, # 9, p. 1949 - 1959
  • 6
  • [ 2623-87-2 ]
  • [ 2969-81-5 ]
YieldReaction ConditionsOperation in experiment
85.5% With hydrogenchloride In 1,4-dioxane; ethanol; dichloromethane Part A
Preparation of ethyl 4-bromobutyrate
To a solution of 4-bromobutyric acid (3 g, 18 mmol) in ethanol (30 mL) was added 5 mL of 4N HCl in dioxane.
The reaction mixture was stirred for 16 hours at room temperature, and then the volatile components were removed under vacuum.
The concentrated residue was brought up in 150 mL of methylene chloride.
The organic solution was washed with saturated aqueous NaHCO3 (1 x 150 mL), brine (1*150 mL), dried over MgSO4, filtered, and the filtrate was concentrated at reduced pressure.
The concentrated residue was dried in vacuo to give 3 g (85.5percent) of the known product as a yellow oil. 1 H NMR (300 MHz/CDCl3): δ 1.22 (t, 3H, J=7.15 Hz), 2.13 (overlapping t, 2H, J=6.80 Hz), 2.45 (t, 2H, J=7.15 Hz), 3.43 (t, 2H, J=6.44 Hz), 4.10 (q, 2H, J=7.25 Hz).
Reference: [1] Patent: US5753660, 1998, A,
  • 7
  • [ 2623-87-2 ]
  • [ 603-35-0 ]
  • [ 17857-14-6 ]
YieldReaction ConditionsOperation in experiment
92% for 48 h; Inert atmosphere; Reflux General procedure: A mixture of ω-bromocarboxylic acid (1 equiv) and triphenylphosphine (1 equiv) in 300 mL of toluene was refluxed for 48 h under argon. The mixture was allowed to cool at room temperature and concentrated in vacuum. The residue was crystallized from various solvents to give the corresponding phosphonium salt.
89% at 120℃; for 16 h; Inert atmosphere General procedure: Triphenylphosphine (3.76g, 14.34mmol) and ethyl 4-bromobutyrate (2.0g, 10.25mmol) were added to a dried round bottom flask under argon. The reaction mixture was heated to 120°C under condenser for 16h after which the reaction was allowed to come to room temperature. CH2Cl2 (10mL) was added, followed by diethyl ether until no further precipitation of product was observed. The precipitate was further washed with ether (100mL) and dried in vacuo to give pure compound 2 as a white solid (4.64g) in quantitative yield.
74% for 15 h; Reflux; Inert atmosphere Compound 14 was synthesized according to the method of Yeung.1 To a flame-dried 50 mL flask under argon equipped with a magnetic stirring bar was added a solution of γ-bromoacid 13 (2.50 g, 14.9 mmol, 1.00 eq.) in 20 mL of anhydrous acetonitrile. Solid triphenylphosphine (3.94 g, 14.9 mmol, 1.00 eq.) was added, the flask was equipped with a water-cooled condenser, and the reaction mixture was heated to reflux. Upon heating, all of the triphenylphosphine gradually dissolved to give an almost colorless solution; after 20 minutes, a white precipitate of the phosphonium started to form. After heating at reflux for 15 hours, the reaction mixture was allowed to cool slowly to room temperature. The precipitate was collected by vacuum filtration, washed with two 5 mL portions of cold acetonitrile, and dried under high vacuum to give pure phosphonium salt 14 (3.03 g, 47percent) as a fine white solid [mp 245–247.5 °C]. Evaporation of the filtrate afforded a yellow/orange solid that was triturated with a minimum amount of cold acetonitrile to give an additional 1.72 g (27percent) of 14 as a pale yellow powder.
64.2% at 105℃; for 48 h; Experimental procedure: Take a 250mL single-mouth round bottom flask,4-bromobutyric acid 1 (15.0 g, 1.0 eq) was added in succession.MeCN (120.0 mL) and triphenylphosphine (23.6 g, 1.0 eq).Heat to reflux, reflux temperature 105 °C,The reaction solution was a yellow liquid and reacted for about 2 days.Post-reaction treatment: The reaction system was directly filtered with a fritted funnel, washed with diethyl ether, and then vacuum-dried to obtain a white solid with a yield of 64.2percent.

Reference: [1] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 1, p. 567 - 579
[2] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 21, p. 5088 - 5102
[3] Zeitschrift fur Naturforschung - Section B Journal of Chemical Sciences, 2002, vol. 57, # 3, p. 335 - 337
[4] Tetrahedron Letters, 2016, vol. 57, # 10, p. 1083 - 1086
[5] Journal of the American Chemical Society, 2018, vol. 140, # 17, p. 5805 - 5813
[6] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 21, p. 5878 - 5881
[7] Patent: CN106946700, 2017, A, . Location in patent: Paragraph 0030; 0031; 0032
[8] Organic Letters, 2016, vol. 18, # 10, p. 2395 - 2398
[9] Journal of Organic Chemistry, 1989, vol. 54, # 17, p. 4224 - 4228
[10] Chemische Berichte, 1977, vol. 110, p. 3544 - 3552
[11] Journal of Organic Chemistry, 1991, vol. 56, # 13, p. 4196 - 4204
[12] Journal of Medicinal Chemistry, 1985, vol. 28, # 3, p. 287 - 294
[13] Journal of Medicinal Chemistry, 2008, vol. 51, # 12, p. 3487 - 3498
[14] Patent: US6753449, 2004, B2, . Location in patent: Page column 15
[15] Organic Letters, 2011, vol. 13, # 10, p. 2738 - 2741
[16] Angewandte Chemie - International Edition, 2012, vol. 51, # 9, p. 2187 - 2190
[17] Journal of Organic Chemistry, 2013, vol. 78, # 5, p. 1718 - 1729
[18] Applied Catalysis A: General, 2014, vol. 470, p. 183 - 188
[19] Organic Letters, 2016, vol. 18, # 3, p. 504 - 507
[20] Organic Letters, 2017, vol. 19, # 18, p. 4940 - 4943
[21] European Journal of Medicinal Chemistry, 2018, vol. 155, p. 275 - 284
[22] Patent: WO2018/106928, 2018, A1, . Location in patent: Page/Page column 29; 32
  • 8
  • [ 2623-87-2 ]
  • [ 75-65-0 ]
  • [ 110661-91-1 ]
YieldReaction ConditionsOperation in experiment
47% With sulfuric acid; magnesium sulfate In dichloromethane at 20℃; for 48 h; Compound 31 was synthesized in accordance with the following scheme. 4-bromo-butyric acid (2.57 g, 15.39 mmol, 1 eq.) was dissolved in dichloromethane (20 ml), magnesium sulfate (7.74 g, 64.30 mmol, 4.2 eq.), tert-butyl alcohol (5.70 g, 76.95 mmol, 5 eq.), and concentrated sulfuric acid (0.25 mE) were added, and the mixture was stirred for 2 days at room temperature. A saturated aqueous sodium hydrogen carbonate solution was added and extracted using dichloromethane, the organic layer was then washed using a saturated sodium chloride solution and dried using anhydrous sodium sulfate, and the solvent was removed under reduced pressure. The resulting residue was purified by medium-pressure silica gel chromatography (eluent:n-hexane/ethyl acetate=50/50) to obtain the objective compound 31(1.17 g, 5.24 mmol, 47percent). 1H NMR (400 MHz, CDCl3): δ 1.27 (s, 9H),1.91-1.98 (m, 2H), 2.22 (t, 2H, J=7.2 Hz), 3.27 (t, 2H, J=6.5Hz); 13C NMR (100 MHz, CDCl3): δ 27.9, 28.0, 32.8, 33.7,80.5, 171.7.
Reference: [1] Tetrahedron Asymmetry, 2004, vol. 15, # 8, p. 1247 - 1258
[2] ACS Combinatorial Science, 2016, vol. 18, # 12, p. 710 - 722
[3] Angewandte Chemie - International Edition, 2010, vol. 49, # 15, p. 2738 - 2742
[4] European Journal of Organic Chemistry, 2003, # 8, p. 1486 - 1493
[5] Patent: US2018/52109, 2018, A1, . Location in patent: Paragraph 0156; 0157; 0158; 0159
[6] Advanced Synthesis and Catalysis, 2007, vol. 349, # 3, p. 432 - 440
[7] Synthesis, 2010, # 24, p. 4261 - 4267
[8] Tetrahedron, 1992, vol. 48, # 42, p. 9277 - 9282
[9] Patent: WO2004/65491, 2004, A1, . Location in patent: Page 22
  • 9
  • [ 2623-87-2 ]
  • [ 115-11-7 ]
  • [ 110661-91-1 ]
YieldReaction ConditionsOperation in experiment
32% With sulfuric acid In dichloromethane at -78 - 20℃; for 72 h; 4-Bromobutanoic acid (9.76 g, 58.4 mmol) and concentrated H2SO4 (3 drops) were dissolved in CH2Cl2 (20 mL) and the mixture was cooled to -78 °C. Isobutylene was bubbled into the solution until the volume doubled. The reaction mixture was stirred for 3 days at room temperature before it was cooled to -78 °C and N2 was bubbled into the reaction mixture to remove excess isobutylene. The reaction mixture was diluted with CH2Cl2 and washed with aqueous 2 N KOH and saturated aqueous NaCl, and concentrated to yield tert-buty\\ 4-bromobutanoate (4.13 g, 32percent) which required no further purification.
Reference: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 14, p. 3359 - 3368
[2] Patent: WO2008/150492, 2008, A1, . Location in patent: Page/Page column 81
  • 10
  • [ 2623-87-2 ]
  • [ 115-11-7 ]
  • [ 65868-63-5 ]
  • [ 110661-91-1 ]
Reference: [1] Patent: US2002/68722, 2002, A1,
  • 11
  • [ 2623-87-2 ]
  • [ 100-51-6 ]
  • [ 126430-46-4 ]
YieldReaction ConditionsOperation in experiment
70%
Stage #1: With S-phenyl benzenethiosulfinate; diisopropyl-carbodiimide In dichloromethane at 20℃; for 2 h;
General procedure: General Procedure for Benzyl Protection of the Bromo-Acid (1c, 1d) [0103] Diisopropylcarbodiimide (DIC) (3.59 mmol, 1.3 eq) was added to a mixture of the bromo-acid (4-bromobutyric acid or 5-bromovaleric acid) (2.76 mmol, 1 eq) and DPTS (3.04 mmol, 1.1 eq) in dry DCM (30 mL) and was allowed to react for 2 hours at room temperature. Benzyl alcohol (4.14 mmol, 1.5 eq) was added and allowed to react overnight. The reaction was washed water and brine, and the DCM was removed by evaporation. Hexanes was added and the resulting white precipitate was removed by filtration. The hexanes was removed from the filtrate by evaporation resulting in an oil which was purified by silica gel chromatography (Hexanes/Ethyl Acetate 3.5/1). Benzyl 4-bromobutyrate (1c) [0104] 70percent yield [0105] 1H NMR (500 MHz, CDCl3) 2.22 (p 2H), 2.58 (t, 2H), 3.48 (t, 2H), 5.16 (s, 2H), 7.40 (m, 5H) [0106] 13C NMR (125 MHz, CDCl3): 28.0, 32.7, 33.0, 66.7, 128.5, 128.6, 128.9, 136.1, 172.6
Reference: [1] European Journal of Organic Chemistry, 2008, # 15, p. 2592 - 2600
[2] Advanced Synthesis and Catalysis, 2007, vol. 349, # 3, p. 432 - 440
[3] Journal of Organic Chemistry, 2001, vol. 66, # 12, p. 4115 - 4121
[4] Journal of the American Chemical Society, 2011, vol. 133, # 41, p. 16346 - 16349
[5] Patent: US2013/302258, 2013, A1, . Location in patent: Paragraph 0102; 0103; 0104; 0105; 0106
[6] Chemistry - A European Journal, 2016, vol. 22, # 4, p. 1270 - 1276
[7] Patent: EP1544208, 2005, A1, . Location in patent: Page/Page column 58
  • 12
  • [ 2623-87-2 ]
  • [ 501-53-1 ]
  • [ 126430-46-4 ]
Reference: [1] MedChemComm, 2015, vol. 6, # 3, p. 403 - 406
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 2623-87-2 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 30515-28-7

[ 30515-28-7 ]

7-Bromoheptanoic acid

Similarity: 0.95

Chemical Structure| 2067-33-6

[ 2067-33-6 ]

5-Bromopentanoic acid

Similarity: 0.95

Chemical Structure| 2536-35-8

[ 2536-35-8 ]

16-Bromohexadecanoic acid

Similarity: 0.95

Chemical Structure| 41059-02-3

[ 41059-02-3 ]

9-Bromononanoic acid

Similarity: 0.95

Chemical Structure| 2834-05-1

[ 2834-05-1 ]

11-Bromoundecanoic acid

Similarity: 0.95

Bromides

Chemical Structure| 30515-28-7

[ 30515-28-7 ]

7-Bromoheptanoic acid

Similarity: 0.95

Chemical Structure| 2067-33-6

[ 2067-33-6 ]

5-Bromopentanoic acid

Similarity: 0.95

Chemical Structure| 2536-35-8

[ 2536-35-8 ]

16-Bromohexadecanoic acid

Similarity: 0.95

Chemical Structure| 41059-02-3

[ 41059-02-3 ]

9-Bromononanoic acid

Similarity: 0.95

Chemical Structure| 2834-05-1

[ 2834-05-1 ]

11-Bromoundecanoic acid

Similarity: 0.95

Carboxylic Acids

Chemical Structure| 30515-28-7

[ 30515-28-7 ]

7-Bromoheptanoic acid

Similarity: 0.95

Chemical Structure| 2067-33-6

[ 2067-33-6 ]

5-Bromopentanoic acid

Similarity: 0.95

Chemical Structure| 2536-35-8

[ 2536-35-8 ]

16-Bromohexadecanoic acid

Similarity: 0.95

Chemical Structure| 41059-02-3

[ 41059-02-3 ]

9-Bromononanoic acid

Similarity: 0.95

Chemical Structure| 2834-05-1

[ 2834-05-1 ]

11-Bromoundecanoic acid

Similarity: 0.95